.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Bladder cancer presents a clinical paradox where men suffer higher incidence but women face worse outcomes. However, recent advances in bladder cancer gene expression research now provide clarity on these differences. A study of 51 patients used transcriptome sequencing to compare tumor tissues with healthy mucosa. The results highlight a major divergence in how the disease manifests at a molecular level between sexes.
The research revealed that males have far more upregulated genes in tumor tissues compared to females. Specifically, the study identified 3,989 genes unique to male patients, while only 753 were unique to females. Male-specific expression patterns linked predominantly to cell cycle regulation and androgen receptor signaling. In contrast, female-specific patterns showed significant enrichment in immune-related pathways. These pathways include lymphocyte differentiation and leukocyte activation, which may influence how women respond to immunotherapy. Notably, overwhelmingly more upregulated genes appeared in male tissues than in female tissues during the comparison.
Notably, a two-factor interaction model pinpointed S100A14 as a critical sex-dependent gene. This protein-coding gene showed a significant interaction effect, suggesting it functions differently in male and female bladders. Furthermore, genes like GJB2 and DSC2 also showed probable sex-dependent interactions. These findings are essential because they provide a foundation for precision medicine. Therefore, doctors can potentially use these biomarkers to tailor surveillance and treatment plans more effectively. Indeed, the identification of these unique markers could pave the way for gender-specific therapeutic approaches.
Ultimately, this research underscores the necessity of considering biological sex in urological oncology. While clinicians currently use similar protocols for both genders, the molecular evidence suggests a need for sex-specific management. Future studies must validate these findings to improve survival rates and reduce recurrence for all bladder cancer patients.
Differences arise due to sex chromosomes, hormonal signaling, and distinct immune responses. These biological factors drive unique molecular pathways in tumor development, leading to different clinical presentations.
S100A14 is a protein-coding gene that exhibits a unique sex-dependent expression pattern. Researchers consider it a potential biomarker that could guide personalized treatment strategies in the future.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice and should not be used for diagnosis or treatment. Refer to the latest local and national guidelines for clinical practice.
References
Zeber-Lubecka N et al. Sex-related differences in gene expression in early-stage bladder cancer revealed by whole-transcriptome sequencing. BMC Cancer. 2026 Feb 09. doi: 10.1186/s12885-026-15666-3. PMID: 41663990.
Mun DH, Kimura S, Shariat SF, Abufaraj M. The impact of gender on oncologic outcomes of bladder cancer. Curr Opin Urol. 2019 Mar;29(2):279-285. doi: 10.1097/MOU.0000000000000606.
Yao R et al. Expression profile and functional role of S100A14 in human cancer. PeerJ. 2019 Apr 26;7:e6812. doi: 10.7717/peerj.6812.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A study reveals sex-specific gene expression patterns in early-stage bladder cancer, highlighting the need for tailored management strategies for men and wo...
5 months ago
Andhra Pradesh reported 10 new Covid-19 cases, taking the state tally to 49 while deaths remain at four. With 24 patients hospitalized and 16 under home isolation, the Health Department has intensified monitoring. Medical professionals should review regional distribution, diagnostic protocols, and management plans.
Today
An 11-year Swedish registry study of 618 uterine sarcoma patients found that minimally invasive surgery yielded survival comparable to open surgery in early stages. However, adjuvant chemotherapy conferred no survival benefit in localized or advanced disease, highlighting stage and histology as key outcomes.
3 days back
A cross-sectional study evaluates post-intensive care syndrome in cardiac patients 2-4 weeks post-ICU discharge, highlighting cognitive, psychological, and functional impairments and the need for structured multidisciplinary rehabilitation.
3 days back
Anterior cruciate ligament reconstruction failure lacks uniform definition. A narrative review proposes an integrative framework incorporating objective and subjective instability, persistent pain, restricted motion, graft rupture, and secondary meniscal injury to standardize clinical reporting.
3 days back
With World Obesity Atlas data warning that over 41 million Indian children are overweight or obese, ICMR and NIN have unveiled a 10-point policy roadmap. The initiative calls for mandatory front-of-pack labeling, HFSS taxes, strict marketing bans, and healthier school environments to curb non-communicable diseases.
Today
